To dismantle the infrastructure for preventative, community-based health and shift focus to individualized, pharmaceutical "solutions."
Slash budgets for the CDC and EPA, redirecting funds to public-private partnerships with pharmaceutical companies, focusing research on "personalized medicine" over environmental causes of disease.
Legal Advocacy,Project Management,Facilitation
Agencies defunded; research redirected; increased pharmaceutical partnerships.
Public backlash; legal challenges; negative health outcomes.
Regulatory Approval,Legal Advocacy
Legal Templates,Digital Platforms,Meeting Spaces
Monitor public sentiment; adjust funding allocations; provide public education.
